SlideShare a Scribd company logo
1 of 20
Canadian Diabetes Association
Clinical Practice Guidelines
Hyperglycemic Emergencies in
Adults
Dr.Saeid Khezer
Family physician
Kurdistan / Duhok
guidelines.diabetes.ca | 1-800-BANTING (226-8464) | diabetes.ca
Copyright © 2013 Canadian Diabetes Association
Key Points
1. Suspect DKA or HHS in an ill patient with
hyperglycemia (usually) – medical emergency
2. DKA = ketoacidosis is prominent
3. HHS = ECFV contraction + hyperosmolarity
4. Rx = FLUIDS, POTASSIUM, INSULIN (DKA)
5. Treat precipitating cause
6. Prevention is critical
2013
guidelines.diabetes.ca | 1-800-BANTING (226-8464) | diabetes.ca
Copyright © 2013 Canadian Diabetes Association
Hyperglycemic Emergencies
• DKA = Diabetic Ketoacidosis
• HHS = Hyperosmolar Hyperglycemic State
• Common features:
– Insulin deficiency  hyperglycemia  urinary loss of water
and electrolytes
 Volume depletion + electrolyte deficiency +
hyperosmolarity
– Insulin deficiency (absolute) + glucagon
 Ketoacidosis (in DKA)
guidelines.diabetes.ca | 1-800-BANTING (226-8464) | diabetes.ca
Copyright © 2013 Canadian Diabetes Association
DKA
• Ketoacidosis
• ECFV contraction
• Milder hyperosmolarity
• Normal to high glucose
• May haveLOC
• Beware hypokalemia
• Must use insulin
• Absolute insulin deficiency +
glucagon
HHS
• Minimal acid-base problem
• ECFV contraction
• Hyperosmolarity
• Marked hyperglycemia
• Marked LOC
• Beware hypokalemia
• May need insulin
• Relative insulin deficiency
ECFV = extracellular fluid volume; LOC = level of consciousness
Suspect DKA or HHS in an ILL Patient with
Hyperglycemia (usually)
guidelines.diabetes.ca | 1-800-BANTING (226-8464) | diabetes.ca
Copyright © 2013 Canadian Diabetes Association
• pH ≤7.3
• Bicarbonate ≤15 mmol/L
• Anion gap >12 mmol/L
= (sodium + potassium) – (chloride + bicarbonate)
• Positive serum or urine ketones
• Plasma glucose ≥14 mmol/L (but may be lower)
• Precipitating factor
Suspect DKA if……
guidelines.diabetes.ca | 1-800-BANTING (226-8464) | diabetes.ca
Copyright © 2013 Canadian Diabetes Association
Be Aware of Conditions that may make DKA
Diagnosis Difficult
• Mixed acid base disorder (eg. vomiting may raise the
bicarbonate)
• Pregnancy  normal to minimally elevated glucose
levels
• Normal AG due to loss of ketones from osmotic
diuresis
• Negative serum ketones due to β-hydroxybutarate
  AG + negative serum ketones = order serum
β-hydroxybutarate
 Always order both urine and serum ketones
guidelines.diabetes.ca | 1-800-BANTING (226-8464) | diabetes.ca
Copyright © 2013 Canadian Diabetes Association
Management of DKA in Adults
guidelines.diabetes.ca | 1-800-BANTING (226-8464) | diabetes.ca
Copyright © 2013 Canadian Diabetes Association
Fluids, Potassium, Acidosis are the Pillars of
Treatment
IV fluids AcidosisSerum
Potassium
guidelines.diabetes.ca | 1-800-BANTING (226-8464) | diabetes.ca
Copyright © 2013 Canadian Diabetes Association
Replace Fluids with IV 0.9% NaCl until
Euvolemic
guidelines.diabetes.ca | 1-800-BANTING (226-8464) | diabetes.ca
Copyright © 2013 Canadian Diabetes Association
Once euvolemic, consider plasma Na+ and
glucose to determine IV fluid type
guidelines.diabetes.ca | 1-800-BANTING (226-8464) | diabetes.ca
Copyright © 2013 Canadian Diabetes Association
Replace Potassium: Hypokalemia is an
avoidable cause of death in DKA
Correct K+ first
THEN
start insulin
guidelines.diabetes.ca | 1-800-BANTING (226-8464) | diabetes.ca
Copyright © 2013 Canadian Diabetes Association
Management of Acidosis with Insulin
Insulin should
be maintained
until the anion
gap normalizes
Insulin used to
treat the
acidosis, not
the glucose!
guidelines.diabetes.ca | 1-800-BANTING (226-8464) | diabetes.ca
Copyright © 2013 Canadian Diabetes Association
Identify and Treat the Precipitating Factor
• Insulin omission – MOST COMMON CAUSE of DKA
• New diagnosis of diabetes
• Infection / Sepsis
• Myocardial infarction
– Small rise in troponin may occur without overt ischemia
– ECG changes may reflect hyperkalemia
• Thyrotoxicosis
• Drugs
guidelines.diabetes.ca | 1-800-BANTING (226-8464) | diabetes.ca
Copyright © 2013 Canadian Diabetes Association
PREVENTION of DKA / HHS
• Type 1 diabetes
– Education around sick day management
– Continuation of insulin even when not eating
– Frequent monitoring when ill
• Type 2 diabetes
– Education around sick day management
– Frequent monitoring when ill
guidelines.diabetes.ca | 1-800-BANTING (226-8464) | diabetes.ca
Copyright © 2013 Canadian Diabetes Association
1. In adult patients with DKA, a protocol should be
followed that incorporates the following principles of
treatment [Grade D, Consensus]
a) Fluid resuscitation
b) Avoidance of hypokalemia
c) Insulin administration
d) Avoidance of rapidly falling serum osmolality
e) Search for precipitating cause
(See figure 1)
Recommendation 1
guidelines.diabetes.ca | 1-800-BANTING (226-8464) | diabetes.ca
Copyright © 2013 Canadian Diabetes Association
2. In adult patients with HHS, a protocol should be
followed that incorporates the following principles of
treatment [Grade D, Consensus]:
a) Fluid resuscitation
b) Avoidance of hypokalemia
c) Avoidance of rapidly falling serum osmolality
d) Search for precipitating cause
e) Possibly insulin to further reduce hyperglycemia
(See figure 1)
Recommendation 2
guidelines.diabetes.ca | 1-800-BANTING (226-8464) | diabetes.ca
Copyright © 2013 Canadian Diabetes Association
3. Point-of-care capillary beta-hydroxybutyrate, if
available, may be measured in the hospital in
patients with T1DM with capillary glucose >14
mmol/L to screen for DKA and a beta-
hydroybutyrate >1.5 mmol/L warrants further
testing for DKA [Grade C, level 2]
Recommendation 3 2013
guidelines.diabetes.ca | 1-800-BANTING (226-8464) | diabetes.ca
Copyright © 2013 Canadian Diabetes Association
4. In individuals with DKA, IV 0.9% sodium chloride
should be administered initially at 500 mL/hour for 4
hours, then 250 mL/hour for 4 hours [Grade B, Level 2]
with consideration of a higher initial rate (1–2 L/hour)
in the presence of shock [Grade D, Consensus]
For persons with HHS, IV fluid administration
should be individualized based on the patient’s
needs [Grade D, Consensus]
Recommendation 4
guidelines.diabetes.ca | 1-800-BANTING (226-8464) | diabetes.ca
Copyright © 2013 Canadian Diabetes Association
5. In individuals with DKA, an infusion of short-acting
IV insulin of 0.10 U/kg/hour should be used [Grade B,
Level 2]
The insulin infusion rate should be maintained until
the resolution of ketosis [Grade B, Level 2] as measured
by the normalization of the plasma anion gap [Grade D,
Consensus]
Once the plasma glucose concentration reaches
14.0 mmol/L, IV dextrose should be started to avoid
hypoglycemia [Grade D, Consensus]
Recommendation 5
guidelines.diabetes.ca | 1-800-BANTING (226-8464) | diabetes.ca
Copyright © 2013 Canadian Diabetes Association
CDA Clinical Practice Guidelines
http://guidelines.diabetes.ca – for professionals
1-800-BANTING (226-8464)
http://diabetes.ca – for patients

More Related Content

What's hot

24 Common Ketoacidosis
24 Common Ketoacidosis24 Common Ketoacidosis
24 Common Ketoacidosis
cindynarak
 

What's hot (20)

Diabetic ketoacidosis/DKA
Diabetic ketoacidosis/DKADiabetic ketoacidosis/DKA
Diabetic ketoacidosis/DKA
 
Diabetic Ketoacidosis
Diabetic KetoacidosisDiabetic Ketoacidosis
Diabetic Ketoacidosis
 
DKA
DKADKA
DKA
 
Diabetic keto acidosis
Diabetic keto acidosisDiabetic keto acidosis
Diabetic keto acidosis
 
Dka 1
Dka 1Dka 1
Dka 1
 
Diabetic Ketoacidosis and Hyperglycemic Hyperosmolar State
Diabetic Ketoacidosis and Hyperglycemic Hyperosmolar StateDiabetic Ketoacidosis and Hyperglycemic Hyperosmolar State
Diabetic Ketoacidosis and Hyperglycemic Hyperosmolar State
 
JOURNAL diabetic ketoacidosis
JOURNAL  diabetic ketoacidosisJOURNAL  diabetic ketoacidosis
JOURNAL diabetic ketoacidosis
 
Diabetic ketoacidosis DKA
Diabetic ketoacidosis DKADiabetic ketoacidosis DKA
Diabetic ketoacidosis DKA
 
24 Common Ketoacidosis
24 Common Ketoacidosis24 Common Ketoacidosis
24 Common Ketoacidosis
 
Dka
DkaDka
Dka
 
Dka cerebral
Dka cerebralDka cerebral
Dka cerebral
 
DIABETIC KETOACIDOSIS GUIDELINES
DIABETIC KETOACIDOSIS GUIDELINESDIABETIC KETOACIDOSIS GUIDELINES
DIABETIC KETOACIDOSIS GUIDELINES
 
Dka
DkaDka
Dka
 
Management of diabetic ketoacidosis dka
Management of diabetic ketoacidosis dkaManagement of diabetic ketoacidosis dka
Management of diabetic ketoacidosis dka
 
Diabetic ketoacidosis: a case study
Diabetic ketoacidosis: a case studyDiabetic ketoacidosis: a case study
Diabetic ketoacidosis: a case study
 
DKA
DKADKA
DKA
 
DKA in children
DKA in childrenDKA in children
DKA in children
 
Medical nutrition therapy for Hemodialysis
Medical nutrition therapy for HemodialysisMedical nutrition therapy for Hemodialysis
Medical nutrition therapy for Hemodialysis
 
DKA in children
DKA in childrenDKA in children
DKA in children
 
Diabetic Ketoacidosis
Diabetic KetoacidosisDiabetic Ketoacidosis
Diabetic Ketoacidosis
 

Similar to Ch15hyperglycemicemergencies 160409211505

Ch15_HyperglycemicEmergencies.pptx
Ch15_HyperglycemicEmergencies.pptxCh15_HyperglycemicEmergencies.pptx
Ch15_HyperglycemicEmergencies.pptx
TakakuYoshiro
 
dkadrsyed2584-190602083813 (1).pptx
dkadrsyed2584-190602083813 (1).pptxdkadrsyed2584-190602083813 (1).pptx
dkadrsyed2584-190602083813 (1).pptx
AhmedMandour37
 
DKA by Dr. A. Mandour.pptx
DKA by Dr. A. Mandour.pptxDKA by Dr. A. Mandour.pptx
DKA by Dr. A. Mandour.pptx
AhmedMandour37
 

Similar to Ch15hyperglycemicemergencies 160409211505 (20)

New treatment for Diabetes Mellitus and Drugs to treat Hypoglycemia
New treatment for Diabetes Mellitus and Drugs to treat HypoglycemiaNew treatment for Diabetes Mellitus and Drugs to treat Hypoglycemia
New treatment for Diabetes Mellitus and Drugs to treat Hypoglycemia
 
Ch15_HyperglycemicEmergencies.pptx
Ch15_HyperglycemicEmergencies.pptxCh15_HyperglycemicEmergencies.pptx
Ch15_HyperglycemicEmergencies.pptx
 
dkadrsyed2584-190602083813 (1).pptx
dkadrsyed2584-190602083813 (1).pptxdkadrsyed2584-190602083813 (1).pptx
dkadrsyed2584-190602083813 (1).pptx
 
DKA by Dr. A. Mandour.pptx
DKA by Dr. A. Mandour.pptxDKA by Dr. A. Mandour.pptx
DKA by Dr. A. Mandour.pptx
 
dkadrsyed2584-190602083813 (1).pdf
dkadrsyed2584-190602083813 (1).pdfdkadrsyed2584-190602083813 (1).pdf
dkadrsyed2584-190602083813 (1).pdf
 
Sargent noon conference 072618
Sargent noon conference 072618Sargent noon conference 072618
Sargent noon conference 072618
 
Case discussion 3 HHS, DKA
Case discussion 3 HHS, DKACase discussion 3 HHS, DKA
Case discussion 3 HHS, DKA
 
Hyperglycemic emergencies
Hyperglycemic emergenciesHyperglycemic emergencies
Hyperglycemic emergencies
 
fmx18-076-077.pdf
fmx18-076-077.pdffmx18-076-077.pdf
fmx18-076-077.pdf
 
Acute Complications of Diabetes.pptx
Acute Complications of Diabetes.pptxAcute Complications of Diabetes.pptx
Acute Complications of Diabetes.pptx
 
Hyperglycemia
HyperglycemiaHyperglycemia
Hyperglycemia
 
The_management_of_diabetic_ketoacidosis_in_adults_An_updated_guideline.pdf
The_management_of_diabetic_ketoacidosis_in_adults_An_updated_guideline.pdfThe_management_of_diabetic_ketoacidosis_in_adults_An_updated_guideline.pdf
The_management_of_diabetic_ketoacidosis_in_adults_An_updated_guideline.pdf
 
Diabetic Ketoacidosis.pptx
Diabetic Ketoacidosis.pptxDiabetic Ketoacidosis.pptx
Diabetic Ketoacidosis.pptx
 
Diabetes Keto Acidosis management. .pptx
Diabetes Keto Acidosis management. .pptxDiabetes Keto Acidosis management. .pptx
Diabetes Keto Acidosis management. .pptx
 
Diabetic Ketoacidosis.pptx
Diabetic Ketoacidosis.pptxDiabetic Ketoacidosis.pptx
Diabetic Ketoacidosis.pptx
 
3-hyperglycemia.ppt
3-hyperglycemia.ppt3-hyperglycemia.ppt
3-hyperglycemia.ppt
 
Diabetes ketoacidosis
Diabetes ketoacidosisDiabetes ketoacidosis
Diabetes ketoacidosis
 
Dka+hhs
Dka+hhsDka+hhs
Dka+hhs
 
Diabetes Management Pearls Feb 2017
Diabetes Management Pearls Feb 2017Diabetes Management Pearls Feb 2017
Diabetes Management Pearls Feb 2017
 
Metabolic emergencies of diabetis mellitus
Metabolic emergencies of diabetis mellitusMetabolic emergencies of diabetis mellitus
Metabolic emergencies of diabetis mellitus
 

Recently uploaded

Cardiac Impulse: Rhythmical Excitation and Conduction in the Heart
Cardiac Impulse: Rhythmical Excitation and Conduction in the HeartCardiac Impulse: Rhythmical Excitation and Conduction in the Heart
Cardiac Impulse: Rhythmical Excitation and Conduction in the Heart
MedicoseAcademics
 
THORACOTOMY . SURGICAL PERSPECTIVES VOL 1
THORACOTOMY . SURGICAL PERSPECTIVES VOL 1THORACOTOMY . SURGICAL PERSPECTIVES VOL 1
THORACOTOMY . SURGICAL PERSPECTIVES VOL 1
DR SETH JOTHAM
 

Recently uploaded (20)

DEVELOPMENT OF OCCLUSION IN PEDIATRIC DENTISTRY
DEVELOPMENT OF OCCLUSION IN PEDIATRIC DENTISTRYDEVELOPMENT OF OCCLUSION IN PEDIATRIC DENTISTRY
DEVELOPMENT OF OCCLUSION IN PEDIATRIC DENTISTRY
 
Cas 28578-16-7 PMK ethyl glycidate ( new PMK powder) best suppler
Cas 28578-16-7 PMK ethyl glycidate ( new PMK powder) best supplerCas 28578-16-7 PMK ethyl glycidate ( new PMK powder) best suppler
Cas 28578-16-7 PMK ethyl glycidate ( new PMK powder) best suppler
 
Integrated Neuromuscular Inhibition Technique (INIT)
Integrated Neuromuscular Inhibition Technique (INIT)Integrated Neuromuscular Inhibition Technique (INIT)
Integrated Neuromuscular Inhibition Technique (INIT)
 
Scleroderma: Treatment Options and a Look to the Future - Dr. Macklin
Scleroderma: Treatment Options and a Look to the Future - Dr. MacklinScleroderma: Treatment Options and a Look to the Future - Dr. Macklin
Scleroderma: Treatment Options and a Look to the Future - Dr. Macklin
 
linearity concept of significance, standard deviation, chi square test, stude...
linearity concept of significance, standard deviation, chi square test, stude...linearity concept of significance, standard deviation, chi square test, stude...
linearity concept of significance, standard deviation, chi square test, stude...
 
Denture base resins materials and its mechanism of action
Denture base resins materials and its mechanism of actionDenture base resins materials and its mechanism of action
Denture base resins materials and its mechanism of action
 
Cardiac Impulse: Rhythmical Excitation and Conduction in the Heart
Cardiac Impulse: Rhythmical Excitation and Conduction in the HeartCardiac Impulse: Rhythmical Excitation and Conduction in the Heart
Cardiac Impulse: Rhythmical Excitation and Conduction in the Heart
 
PT MANAGEMENT OF URINARY INCONTINENCE.pptx
PT MANAGEMENT OF URINARY INCONTINENCE.pptxPT MANAGEMENT OF URINARY INCONTINENCE.pptx
PT MANAGEMENT OF URINARY INCONTINENCE.pptx
 
180-hour Power Capsules For Men In Ghana
180-hour Power Capsules For Men In Ghana180-hour Power Capsules For Men In Ghana
180-hour Power Capsules For Men In Ghana
 
BMK Glycidic Acid (sodium salt) CAS 5449-12-7 Pharmaceutical intermediates
BMK Glycidic Acid (sodium salt)  CAS 5449-12-7 Pharmaceutical intermediatesBMK Glycidic Acid (sodium salt)  CAS 5449-12-7 Pharmaceutical intermediates
BMK Glycidic Acid (sodium salt) CAS 5449-12-7 Pharmaceutical intermediates
 
In-service education (Nursing Mangement)
In-service education (Nursing Mangement)In-service education (Nursing Mangement)
In-service education (Nursing Mangement)
 
A thorough review of supernormal conduction.pptx
A thorough review of supernormal conduction.pptxA thorough review of supernormal conduction.pptx
A thorough review of supernormal conduction.pptx
 
Why invest into infodemic management in health emergencies
Why invest into infodemic management in health emergenciesWhy invest into infodemic management in health emergencies
Why invest into infodemic management in health emergencies
 
Effects of vaping e-cigarettes on arterial health
Effects of vaping e-cigarettes on arterial healthEffects of vaping e-cigarettes on arterial health
Effects of vaping e-cigarettes on arterial health
 
SURGICAL ANATOMY OF ORAL IMPLANTOLOGY.pptx
SURGICAL ANATOMY OF ORAL IMPLANTOLOGY.pptxSURGICAL ANATOMY OF ORAL IMPLANTOLOGY.pptx
SURGICAL ANATOMY OF ORAL IMPLANTOLOGY.pptx
 
Muscle Energy Technique (MET) with variant and techniques.
Muscle Energy Technique (MET) with variant and techniques.Muscle Energy Technique (MET) with variant and techniques.
Muscle Energy Technique (MET) with variant and techniques.
 
Introducing VarSeq Dx as a Medical Device in the European Union
Introducing VarSeq Dx as a Medical Device in the European UnionIntroducing VarSeq Dx as a Medical Device in the European Union
Introducing VarSeq Dx as a Medical Device in the European Union
 
THORACOTOMY . SURGICAL PERSPECTIVES VOL 1
THORACOTOMY . SURGICAL PERSPECTIVES VOL 1THORACOTOMY . SURGICAL PERSPECTIVES VOL 1
THORACOTOMY . SURGICAL PERSPECTIVES VOL 1
 
CURRENT HEALTH PROBLEMS AND ITS SOLUTION BY AYURVEDA.pptx
CURRENT HEALTH PROBLEMS AND ITS SOLUTION BY AYURVEDA.pptxCURRENT HEALTH PROBLEMS AND ITS SOLUTION BY AYURVEDA.pptx
CURRENT HEALTH PROBLEMS AND ITS SOLUTION BY AYURVEDA.pptx
 
Multiple sclerosis diet.230524.ppt3.pptx
Multiple sclerosis diet.230524.ppt3.pptxMultiple sclerosis diet.230524.ppt3.pptx
Multiple sclerosis diet.230524.ppt3.pptx
 

Ch15hyperglycemicemergencies 160409211505

  • 1. Canadian Diabetes Association Clinical Practice Guidelines Hyperglycemic Emergencies in Adults Dr.Saeid Khezer Family physician Kurdistan / Duhok
  • 2. guidelines.diabetes.ca | 1-800-BANTING (226-8464) | diabetes.ca Copyright © 2013 Canadian Diabetes Association Key Points 1. Suspect DKA or HHS in an ill patient with hyperglycemia (usually) – medical emergency 2. DKA = ketoacidosis is prominent 3. HHS = ECFV contraction + hyperosmolarity 4. Rx = FLUIDS, POTASSIUM, INSULIN (DKA) 5. Treat precipitating cause 6. Prevention is critical 2013
  • 3. guidelines.diabetes.ca | 1-800-BANTING (226-8464) | diabetes.ca Copyright © 2013 Canadian Diabetes Association Hyperglycemic Emergencies • DKA = Diabetic Ketoacidosis • HHS = Hyperosmolar Hyperglycemic State • Common features: – Insulin deficiency  hyperglycemia  urinary loss of water and electrolytes  Volume depletion + electrolyte deficiency + hyperosmolarity – Insulin deficiency (absolute) + glucagon  Ketoacidosis (in DKA)
  • 4. guidelines.diabetes.ca | 1-800-BANTING (226-8464) | diabetes.ca Copyright © 2013 Canadian Diabetes Association DKA • Ketoacidosis • ECFV contraction • Milder hyperosmolarity • Normal to high glucose • May haveLOC • Beware hypokalemia • Must use insulin • Absolute insulin deficiency + glucagon HHS • Minimal acid-base problem • ECFV contraction • Hyperosmolarity • Marked hyperglycemia • Marked LOC • Beware hypokalemia • May need insulin • Relative insulin deficiency ECFV = extracellular fluid volume; LOC = level of consciousness Suspect DKA or HHS in an ILL Patient with Hyperglycemia (usually)
  • 5. guidelines.diabetes.ca | 1-800-BANTING (226-8464) | diabetes.ca Copyright © 2013 Canadian Diabetes Association • pH ≤7.3 • Bicarbonate ≤15 mmol/L • Anion gap >12 mmol/L = (sodium + potassium) – (chloride + bicarbonate) • Positive serum or urine ketones • Plasma glucose ≥14 mmol/L (but may be lower) • Precipitating factor Suspect DKA if……
  • 6. guidelines.diabetes.ca | 1-800-BANTING (226-8464) | diabetes.ca Copyright © 2013 Canadian Diabetes Association Be Aware of Conditions that may make DKA Diagnosis Difficult • Mixed acid base disorder (eg. vomiting may raise the bicarbonate) • Pregnancy  normal to minimally elevated glucose levels • Normal AG due to loss of ketones from osmotic diuresis • Negative serum ketones due to β-hydroxybutarate   AG + negative serum ketones = order serum β-hydroxybutarate  Always order both urine and serum ketones
  • 7. guidelines.diabetes.ca | 1-800-BANTING (226-8464) | diabetes.ca Copyright © 2013 Canadian Diabetes Association Management of DKA in Adults
  • 8. guidelines.diabetes.ca | 1-800-BANTING (226-8464) | diabetes.ca Copyright © 2013 Canadian Diabetes Association Fluids, Potassium, Acidosis are the Pillars of Treatment IV fluids AcidosisSerum Potassium
  • 9. guidelines.diabetes.ca | 1-800-BANTING (226-8464) | diabetes.ca Copyright © 2013 Canadian Diabetes Association Replace Fluids with IV 0.9% NaCl until Euvolemic
  • 10. guidelines.diabetes.ca | 1-800-BANTING (226-8464) | diabetes.ca Copyright © 2013 Canadian Diabetes Association Once euvolemic, consider plasma Na+ and glucose to determine IV fluid type
  • 11. guidelines.diabetes.ca | 1-800-BANTING (226-8464) | diabetes.ca Copyright © 2013 Canadian Diabetes Association Replace Potassium: Hypokalemia is an avoidable cause of death in DKA Correct K+ first THEN start insulin
  • 12. guidelines.diabetes.ca | 1-800-BANTING (226-8464) | diabetes.ca Copyright © 2013 Canadian Diabetes Association Management of Acidosis with Insulin Insulin should be maintained until the anion gap normalizes Insulin used to treat the acidosis, not the glucose!
  • 13. guidelines.diabetes.ca | 1-800-BANTING (226-8464) | diabetes.ca Copyright © 2013 Canadian Diabetes Association Identify and Treat the Precipitating Factor • Insulin omission – MOST COMMON CAUSE of DKA • New diagnosis of diabetes • Infection / Sepsis • Myocardial infarction – Small rise in troponin may occur without overt ischemia – ECG changes may reflect hyperkalemia • Thyrotoxicosis • Drugs
  • 14. guidelines.diabetes.ca | 1-800-BANTING (226-8464) | diabetes.ca Copyright © 2013 Canadian Diabetes Association PREVENTION of DKA / HHS • Type 1 diabetes – Education around sick day management – Continuation of insulin even when not eating – Frequent monitoring when ill • Type 2 diabetes – Education around sick day management – Frequent monitoring when ill
  • 15. guidelines.diabetes.ca | 1-800-BANTING (226-8464) | diabetes.ca Copyright © 2013 Canadian Diabetes Association 1. In adult patients with DKA, a protocol should be followed that incorporates the following principles of treatment [Grade D, Consensus] a) Fluid resuscitation b) Avoidance of hypokalemia c) Insulin administration d) Avoidance of rapidly falling serum osmolality e) Search for precipitating cause (See figure 1) Recommendation 1
  • 16. guidelines.diabetes.ca | 1-800-BANTING (226-8464) | diabetes.ca Copyright © 2013 Canadian Diabetes Association 2. In adult patients with HHS, a protocol should be followed that incorporates the following principles of treatment [Grade D, Consensus]: a) Fluid resuscitation b) Avoidance of hypokalemia c) Avoidance of rapidly falling serum osmolality d) Search for precipitating cause e) Possibly insulin to further reduce hyperglycemia (See figure 1) Recommendation 2
  • 17. guidelines.diabetes.ca | 1-800-BANTING (226-8464) | diabetes.ca Copyright © 2013 Canadian Diabetes Association 3. Point-of-care capillary beta-hydroxybutyrate, if available, may be measured in the hospital in patients with T1DM with capillary glucose >14 mmol/L to screen for DKA and a beta- hydroybutyrate >1.5 mmol/L warrants further testing for DKA [Grade C, level 2] Recommendation 3 2013
  • 18. guidelines.diabetes.ca | 1-800-BANTING (226-8464) | diabetes.ca Copyright © 2013 Canadian Diabetes Association 4. In individuals with DKA, IV 0.9% sodium chloride should be administered initially at 500 mL/hour for 4 hours, then 250 mL/hour for 4 hours [Grade B, Level 2] with consideration of a higher initial rate (1–2 L/hour) in the presence of shock [Grade D, Consensus] For persons with HHS, IV fluid administration should be individualized based on the patient’s needs [Grade D, Consensus] Recommendation 4
  • 19. guidelines.diabetes.ca | 1-800-BANTING (226-8464) | diabetes.ca Copyright © 2013 Canadian Diabetes Association 5. In individuals with DKA, an infusion of short-acting IV insulin of 0.10 U/kg/hour should be used [Grade B, Level 2] The insulin infusion rate should be maintained until the resolution of ketosis [Grade B, Level 2] as measured by the normalization of the plasma anion gap [Grade D, Consensus] Once the plasma glucose concentration reaches 14.0 mmol/L, IV dextrose should be started to avoid hypoglycemia [Grade D, Consensus] Recommendation 5
  • 20. guidelines.diabetes.ca | 1-800-BANTING (226-8464) | diabetes.ca Copyright © 2013 Canadian Diabetes Association CDA Clinical Practice Guidelines http://guidelines.diabetes.ca – for professionals 1-800-BANTING (226-8464) http://diabetes.ca – for patients

Editor's Notes

  1. DKA or HHS must be suspected in all patients with diabetes presenting with hyperglycemia.
  2. With insulin deficiency, hyperglycemia causes urinary losses of water and electrolytes (sodium, potassium, chloride) and the resultant extracellular fluid volume (ECFV) depletion. Potassium is shifted out of cells (looks high but in fact depletion) Ketoacidosis occurs as a result of elevated glucagon levels and absolute insulin deficiency (in the case of type 1 diabetes) or high catecholamine levels suppressing insulin release (in the case of type 2 diabetes). In DKA, ketoacidosis is prominent while, in HHS, the main features are ECFV depletion and hyperosmolarity.
  3. 3 urgent priorities: restoring ECF volume, resolution of acidosis, replacement of potassium and electrolyte balance Monitoring of volume status (including fluid intake and output), vital signs, neurologic status, plasma concentrations of electrolytes, anion gap, osmolality, and glucose need to be monitored closely, initially as often as every 2 hours
  4. Phosphate repletion if severe hypophosphatemia
  5. No insulin bolus ; some cases of HHS may respond to initial volume (no insulin needed) Do not tailor insulin to glucose: once BG <14, add D5W to solution Can use continuous IV insulin or q1-2 hourly SC insulin: no difference in resolution of ketoacidosis or hypoglycemia risk